0000930413-21-000042.txt : 20210113 0000930413-21-000042.hdr.sgml : 20210113 20210113214518 ACCESSION NUMBER: 0000930413-21-000042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210111 FILED AS OF DATE: 20210113 DATE AS OF CHANGE: 20210113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TAGLIAFERRI MARY CENTRAL INDEX KEY: 0001323304 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 21527398 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 ownership.xml X0306 4 2021-01-11 0 0000316253 ENZO BIOCHEM INC ENZ 0001323304 TAGLIAFERRI MARY C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK NY 10022 1 0 0 0 Stock Option (to acquire Common Stock) 2.63 2021-01-11 4 A 0 77101 0 A 2022-01-11 2026-01-11 Common Stock 77101 77101 D The Reporting Person was granted 77,101 stock options. The stock options have a five-year term and 50% of the stock options will vest on the first anniversary of the grant date and 50% on the second anniversary of the grant date. /s/ Mary Tagliaferri 2021-01-13